What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Fred Hutch's Value in Cancer Care conference, held November 6, focused on patient and provider burnout; the growing data ...

In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...

Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

In this conversation, Petros Grivas, MD, PhD, discusses his new podcast aimed at exploring the latest developments in cancer care and research. He emphasizes the importance of learning from colleagues ...

AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding SEATTLE – Oct. 2, 2024 – Four National Cancer ...

Study aims to understand the effectiveness and use of multi-cancer detection blood tests SEATTLE – July 15, 2025 – Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national ...

During his 36-year career at Fred Hutch Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He and Fred Hutch evolutionary biologist Harmit ...